Journal of Clinical and Aesthetic Dermatology

JUN 2017

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link: http://jcadonline.epubxp.com/i/839245

Contents of this Issue

Navigation

Page 28 of 63

29 JCAD journal of clinical and aesthetic dermatology June 2017 • Volume 10 • Number 6 important when considering the psychosocial effects of rosacea, which do not necessarily correlate with the severity of the disease. 42 Although this survey was large, most participants reported having only mild or moderate disease severity, resulting in a low number of patients with severe ETR and PPR. Another limitation of this type of study is that it collects response data during a narrow window of the participants' experience with rosacea. This necessarily restricted responses regarding participants' usage and experience with rosacea treatments. In addition, it is possible that some PPR patients may have had rosacea that was adequately controlled by topical metronidazole treatment so did not present with more than four papules at the time of the survey. As a result, it is possible that a number of controlled PPR patients were included in the ETR cohort. This potential discrepancy may have had an effect on the comparisons between the ETR and PPR cohorts. CONCLUSION This cross-sectional, survey- based study obtained a wide range of data on individuals with ETR and PPR. Not surprisingly, rosacea signs and symptoms were bothersome to study participants. Yet, despite the chronic nature of the condition, they commonly used prescription agents only to treat rosacea flare-ups and relied instead on sun protection and other avoidance mechanisms to manage their rosacea on a long-term basis. Many participants were not using their prescription therapies, and among those who did, many were not satisfied with the results. Individuals with rosacea are likely to benefit from more education about the different clinical manifestations of rosacea, its chronic and recurrent nature, the need for long-term treatment to decrease the frequency and severity of flare-ups, and the importance of setting reasonable expectations for treatment success. REFERENCES 1. Del Rosso JQ, Thiboutot D, Gallo R, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care. Cutis. 2013;92(5):234–240. 2. Baldwin HE. Diagnosis and treatment of rosacea: state of the art. J Drugs Dermatol. Figure 5. Participants' satisfaction with treatment during the three months prior to the survey. OTC=over-the-counter; Rx=prescription O R I G I N A L R E S E A R C h

Articles in this issue

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - JUN 2017